Zelira Therapeutics Limited (ASX:ZLD)
Australia
· Delayed Price · Currency is AUD 0.4950
+0.0450 (10.00%)
May 21, 2025, 3:51 PM AEST
Zelira Therapeutics Revenue
Zelira Therapeutics had revenue of 655.00 AUD in the half year ending December 31, 2024, a decrease of -99.15%. This brings the company's revenue in the last twelve months to 40.88K, down -85.34% year-over-year. In the fiscal year ending June 30, 2024, Zelira Therapeutics had annual revenue of 94.95K, down -68.47%.
Revenue (ttm)
40.88K
Revenue Growth
-85.34%
P/S Ratio
130.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.35M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |